Avoid aspirin in atrial fibrillation, cardiologist urges

ASPIRIN continues to be misused as thromboprophylaxis in atrial fibrillation (AF) despite being neither effective nor safe, a leading Sydney cardiologist warns.

The default strategy should be to offer all patients with AF either warfarin or a newer oral anticoagulant (NOAC) unless they are low risk, says Professor Ben Freedman, from the Heart Research Institute at the University of Sydney’s Charles Perkins Centre.

“Many strokes that occur in known AF are in people on aspirin and these could have been prevented if we